← Browse by Condition
Medical Condition

stage iii squamous cell carcinoma of the head and neck

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06161545 Phase 2
Recruiting

Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma

Enrollment
40 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →